3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Neoplasms
3
Lymphoma
3
Preleukemia
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Precancerous Conditions
2
Neoplasms by Histologic Type
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoproliferative Disorders
2
Lymphatic Diseases
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Leukemia
2
Immunoproliferative Disorders
2
Immune System Diseases
2
Hematologic Diseases
2
Esophageal Neoplasms
2
Bone Marrow Diseases
2
Sarcoma
1
Primary Myelofibrosis
1
Pathologic Complete Response
1
Osteosarcoma
1
Neoplasms, Second Primary
1
Neoplasms, Plasma Cell
1
Interventions
Magnetic Resonance Spectroscopy
15
Specimen Handling
13
Cisplatin
13
pembrolizumab
10
Radiotherapy, Intensity-Modulated
9
Carboplatin
9
Platinum
8
1,2-diaminocyclohexaneplatinum II citrate
8
Cetuximab
7
Radiotherapy
5
Radiation
5
Paclitaxel
5
Biopsy
5
Taxes
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
Docetaxel
3
ipatasertib
2
durvalumab
2
X-Rays
2
Surgical Procedures, Operative
2
Standard of Care
2
Interviews as Topic
2
Immunoglobulin G
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Disulfides
2
Chemoradiotherapy
2
trametinib
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
Patient Reported Outcome Measures
×
1 year
×
Clear all
No trials found.